Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:02 pm Sale | 2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO | Point72 Asset Management, L.P. | 115,484 0.200% | -1,644,764![]() (-93.44%) | Filing History |
| 2023-02-14 4:02 pm Sale | 2022-12-31 | 13G | Krystal Biotech, Inc. KRYS | Point72 Asset Management, L.P. | 556,252 2.200% | -1,304,418![]() (-70.10%) | Filing History |
| 2023-02-14 4:01 pm Sale | 2022-12-31 | 13G | Affimed N.V. AFMD | Point72 Asset Management, L.P. | 422,701 2.800% | -762,858![]() (-64.35%) | Filing History |
| 2023-02-14 4:01 pm Sale | 2022-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT | Point72 Asset Management, L.P. | 392,151 0.900% | -1,968,718![]() (-83.39%) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | Achilles Therapeutics plc ACHL | Point72 Asset Management, L.P. | 1,413,809 3.600% | -667,241![]() (-32.06%) | Filing History |
| 2023-02-13 8:33 pm Purchase | 2023-02-10 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Point72 Asset Management, L.P. | 1,250,000 6.500% | 1,250,000![]() (New Position) | Filing History |
| 2023-02-08 4:34 pm Purchase | 2023-02-03 | 13G | MediWound Ltd. MDWD | Point72 Asset Management, L.P. | 821,500 8.900% | 821,500![]() (New Position) | Filing History |
| 2023-01-05 5:31 pm Purchase | 2023-01-04 | 13G | Fastly, Inc. FSLY | Point72 Asset Management, L.P. | 6,209,691 5.000% | 6,209,691![]() (New Position) | Filing History |
| 2023-01-04 5:04 pm Purchase | 2023-01-03 | 13G | Pulmonx Corporation LUNG | Point72 Asset Management, L.P. | 1,971,810 5.300% | 1,971,810![]() (New Position) | Filing History |
| 2022-11-14 5:11 pm Purchase | 2022-11-10 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Point72 Asset Management, L.P. | 3,398,661 7.100% | 3,398,661![]() (New Position) | Filing History |
| 2022-11-09 9:10 pm Purchase | 2022-11-03 | 13G | Abeona Therapeutics Inc. ABEO | Point72 Asset Management, L.P. | 960,870 9.990% | 960,870![]() (New Position) | Filing History |
| 2022-11-03 4:18 pm Purchase | 2022-11-02 | 13G | Health Catalyst, Inc. HCAT | Point72 Asset Management, L.P. | 2,784,884 5.100% | 2,784,884![]() (New Position) | Filing History |
| 2022-10-31 8:22 pm Purchase | 2022-10-28 | 13G | GRITSTONE BIO INC GRTSQ | Point72 Asset Management, L.P. | 6,608,558 8.000% | 6,608,558![]() (New Position) | Filing History |
| 2022-10-24 4:37 pm Purchase | 2022-10-12 | 13G | Immunic, Inc. IMUX | Point72 Asset Management, L.P. | 1,917,546 4.900% | 1,917,546![]() (New Position) | Filing History |
| 2022-10-14 9:10 pm Purchase | 2022-10-13 | 13G | Relmada Therapeutics, Inc. RLMD | Point72 Asset Management, L.P. | 2,102,037 7.300% | 2,102,037![]() (New Position) | Filing History |
| 2022-10-11 8:29 pm Purchase | 2022-10-03 | 13G | Intercept Pharmaceuticals, Inc. ICPT | Point72 Asset Management, L.P. | 2,360,869 5.700% | 2,360,869![]() (New Position) | Filing History |
| 2022-10-11 5:05 pm Purchase | 2022-10-10 | 13G | Progress Acquisition Corp. PGRW | Point72 Asset Management, L.P. | 870,229 5.000% | 870,229![]() (New Position) | Filing History |
| 2022-09-22 4:40 pm Purchase | 2022-09-21 | 13G | Reata Pharmaceuticals, Inc. RETA | Point72 Asset Management, L.P. | 1,664,067 5.300% | 1,664,067![]() (New Position) | Filing History |
| 2022-09-13 5:12 pm Purchase | 2022-09-12 | 13G | Eos Energy Enterprises, Inc. EOSE | Point72 Asset Management, L.P. | 3,041,765 5.100% | 3,041,765![]() (New Position) | Filing History |
| 2022-09-09 4:54 pm Purchase | 2022-08-30 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 2,281,200 8.100% | 2,009,971![]() (+741.06%) | Filing History |

